COLLEEN DELANEY

Profile

First Name

: COLLEEN

Middle Name

:

Last Name

: DELANEY

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

NOHLA THERAPEUTICS INC.

BENJAMIN SCOT BERGO, IAN DAVID BROWN, GARY CHRISTIANSON, BRIAN DANIELS, KATHLEEN FANNING, STEVEN GILLIS, LAWRENCE GOZLAN, JIM JOHNSON, DARREN SCOTTI, MICHAEL SISTENICH

EXECUTIVE OFFICER

DEVERRA THERAPEUTICS, INC.

MICHAEL YURKOWSKY, MICHAEL W YURKOWSKY

DIRECTOR

VICAPSYS LIFE SCIENCES, INC.

WILLIAM H. CARSON, CHARLES FARRAHAR, CHARLIE FARRAHAR, LARRY M. GLASSCOCK, STEVE GORLIN, ROBERT P. GRAMMEN, DOROTHY JORDAN, STEPHEN J. MCCORMACK, FEDERICO PIER, FREDERICO PIER, LEONARD POTTER, JOHN T. POTTS, JR., RODGER E. REES, RICHARD ROSENBLUM, RYAN SEDDON, JEFFREY WRIGHT, MICHAEL W. YURKOWSKY

EXECUTIVE OFFICER

COEPTIS THERAPEUTICS HOLDINGS, INC.

CHRISTOPHER CALISE, CHRISTOPHER COCHRAN, BRIAN COGLEY, PHILIPPE DESCHAMPS, TARA MARIA DESILVA, DAVID MEHALICK, GENE SALKIND, CHRISTINE SHEEHY, DANIEL YERACE

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]

DECLINE TO DISCLOSE

Equity

2024-06-14

D

BIOTECHNOLOGY

NO REVENUES

Debt

2023-09-08

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity, Debt

2023-06-28

D

BIOTECHNOLOGY

NO REVENUES

Equity

2020-08-20

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2018-05-01